The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Foundation Researcher Studies Role of IL-17 in Rheumatoid Arthritis

Foundation Researcher Studies Role of IL-17 in Rheumatoid Arthritis

January 2, 2013 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. Shahrara
Dr. Shahrara

Shiva Shahrara, PhD, started her rheumatology research career with a fellowship working in the lab of Alisa Koch, MD, at Northwestern University in Chicago. During her fellowship, she worked on identifying the factors involved in the pathogenesis of rheumatoid arthritis (RA).

You Might Also Like
  • Researcher Studies Ways to Cut Cardiovascular Disease Risk in Rheumatoid Arthritis Patients
  • Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis
  • Rheumatology Research Foundation Grant Aids Investigations Into Rheumatoid Arthritis
Explore This Issue
January 2013
Also By This Author
  • Boost Revenue with Denials Management, Appeals

When Dr. Koch moved to the University of Michigan, Dr. Shahrara started doing her own research into RA pathogenesis with the help of the Within Our Reach RA Research Award from the Rheumatology Research Foundation, which she received in 2008.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“At the time I was applying for the Foundation award, I had a K award through [the National Institutes of Health] NIH that was in its final stages, and I was submitting bigger grants, but usually NIH wants investigators to have smaller grants before committing to five-year grants,” Dr. Shahrara says. “I felt this was a good opportunity. At the time, I was working with a factor called IL-17, and there were a huge number of labs that were interested in this molecule that is produced from a specific type of T cells [TH17], and I became very interested in that because we were among the first labs that identified that IL-17 was important in RA joints.”

Dr. Shahrara wanted study the function of IL-17 in the joints of RA patients. She applied for and received Foundation funding to study the role of IL-17 in RA cells. “Even today the research we’re doing is a continuation and it’s based on our finding from the Foundation [grant],” she says. “[The Rheumatology Research Foundation] was really instrumental in my career because it basically bridged my funding from my K, when my K was in its final phases. The funding provided by the Foundation enabled me to get a big Department of Defense grant, which is comparable to an R01. It really made a significant difference in my career.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Shahrara’s Foundation grant was for two years, with an extension for a third, and has resulted in 14 published papers. The research team learned that IL-17 plays an important role in both recruiting myeloid cells to migrate from the blood to the joint and perpetuating vascularization, either directly or through inducing other chemokines. But her findings went beyond the role of IL-17. Using microarray analysis, Dr. Shahrara and her research team were also able to identify genes that were regulated in RA cells but not normal cells.

Pages: 1 2 | Single Page

Filed Under: From the College Tagged With: foundation, IL-17, Research, Rheumatoid arthritisIssue: January 2013

You Might Also Like:
  • Researcher Studies Ways to Cut Cardiovascular Disease Risk in Rheumatoid Arthritis Patients
  • Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis
  • Rheumatology Research Foundation Grant Aids Investigations Into Rheumatoid Arthritis
  • Rheumatology Research Foundation Funding Aids Researcher’s Career

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)